Akebia Therap

Forecast & Rating6 analysts currently cover Akebia Therap, with about 83.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $3.92, about 876.0% upside from the current price of $0.40. Price targets range from $1.00 to $6.00 — a wide spread, showing clear disagreement over just how much Akebia Therap can rise. Historically, about 28.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Akebia Therap closely still see room for the stock to rise. Data as of Nov 3, 2026; for reference only and not investment advice.